SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-018459
Filing Date
2018-08-01
Accepted
2018-08-01 16:15:22
Documents
3
Period of Report
2018-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20180801.htm 8-K 24011
2 EX-99.1 sbph-ex991_6.htm EX-99.1 163829
3 GRAPHIC gtvje435u4tl000001.jpg GRAPHIC 4287
  Complete submission text file 0001564590-18-018459.txt   195049
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 18984933
SIC: 2834 Pharmaceutical Preparations